Endogenous incretin levels and risk of first incident cancer: a prospective cohort study

Concerns have been raised regarding a potentially increased risk of cancer associated with treatment with glucagon-like peptide-1 (GLP-1) receptor agonists. Here, we explored whether fasting and oral glucose tolerance test post-challenge glucose-dependent insulinotropic peptide (GIP) and GLP-1 level...

Descripción completa

Detalles Bibliográficos
Autores principales: Jujić, Amra, Godina, Christopher, Belting, Mattias, Melander, Olle, Juul Holst, Jens, Ahlqvist, Emma, Gomez, Maria F., Nilsson, Peter M., Jernström, Helena, Magnusson, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825393/
https://www.ncbi.nlm.nih.gov/pubmed/36611045
http://dx.doi.org/10.1038/s41598-023-27509-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825393/
https://www.ncbi.nlm.nih.gov/pubmed/36611045
http://dx.doi.org/10.1038/s41598-023-27509-3

Ejemplares similares